Edition:
United Kingdom

Gensight Biologics SA (SIGHT.PA)

SIGHT.PA on Paris Stock Exchange

1.99EUR
18 Apr 2019
Change (% chg)

€-0.04 (-1.73%)
Prev Close
€2.03
Open
€2.03
Day's High
€2.14
Day's Low
€1.94
Volume
577,127
Avg. Vol
336,622
52-wk High
€5.28
52-wk Low
€1.34

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.481
FY 2017 Dec '17 0.00 -0.507
Jun '17 0.00 -0.622
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 2 3.50 7.00 0.00 25.50
Earnings (per share)
Year Ending Dec-19 2 -0.98 -0.94 -1.02 -1.07
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 109.48 62.40
P/E High - Last 5 Yrs. -- 163.07 56.31
P/E Low - Last 5 Yrs. -- 52.30 28.72
Beta -- 1.16 0.93
Price to Sales (TTM) -- 46.04 9.62
Price to Book (MRQ) 1.08 13.22 4.53
Price to Tangible Book (MRQ) 1.29 18.84 7.71
Price to Cash Flow (TTM) -- 73.00 43.23
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.09 1.54
Dividend Yield - 5 Year Avg -- 0.05 0.70
Dividend 5 Year Growth Rate -- 0.72 2.97
Payout Ratio(TTM) -- 8.42 21.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 23.35 9.20
Sales (TTM) vs TTM 1 Yr. Ago -- 67.54 8.35
Sales - 5 Yr. Growth Rate -- 33.23 11.12
EPS (MRQ) vs Qtr. 1 Yr. Ago 22.69 -90.23 110.61
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 21.68 6.92
Capital Spending - 5 Yr. Growth Rate -- 25.56 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.71 2.66
Current Ratio (MRQ) 10.89 3.55 3.63
LT Debt to Equity (MRQ) 7.63 7.07 13.26
Total Debt to Equity (MRQ) 7.63 20.06 16.97
Interest Coverage (TTM) -- 10.02 27.27

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 25.18 50.31
Gross Margin - 5 Yr. Avg. -- 59.97 50.77
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -10.84 15.78
Operating Margin (TTM) -- -109.08 -2.09
Operating Margin - 5 Yr. Avg. -- -26.44 11.11
Pre-Tax Margin (TTM) -- -109.66 -2.92
Pre-Tax Margin - 5 Yr. Avg. -- -29.17 16.76
Net Profit Margin (TTM) -- -116.04 -6.86
Net Profit Margin - 5 Yr. Avg. -- -34.35 11.72
Effective Tax Rate (TTM) -- 19.91 22.86
Effective Tax Rate - 5 Yr. Avg. -- 19.61 23.86

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 8,511,584 773,166,387
Net Income/Employee (TTM) -754,618 1,995,061 89,056,262
Receivable Turnover (TTM) -- 2.36 5.22
Inventory Turnover (TTM) -- 2.31 3.65
Asset Turnover (TTM) 0.00 0.32 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -40.45 6.35 9.54
Return on Assets - 5 Yr. Avg. -- 6.24 10.49
Return on Investment (TTM) -43.80 7.96 11.78
Return on Investment - 5 Yr. Avg. -- 8.16 13.39
Return on Equity (TTM) -46.27 8.11 12.61
Return on Equity - 5 Yr. Avg. -- 9.28 14.86
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 19.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Gensight Biologics SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.93 -6.43 99 90
13 Week -32.31 -41.85 22 74
26 Week 6.13 -2.68 99 4
52 Week -35.60 -37.91 77 26
YTD -40.24 -49.34 15 23
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 53.02%
# of Holders: 15
Total Shares Held: 15,229,171
3 Mo. Net Change: 3,717,183
# New Positions: 4
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 1
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.